logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Myocardial Infarction

    FiltersReset Filters
    51 results
    • activase

      (Alteplase)
      Genentech, Inc.
      Usage: Activase is indicated for the treatment of acute ischemic stroke, acute myocardial infarction (AMI) to reduce mortality and heart failure incidence, and lysis of acute massive pulmonary embolism with significant obstruction or unstable hemodynamics. Treatment should be initiated quickly, particularly for stroke within 3 hours of symptom onset.
    • atenolol

      (Atenolol)
      Nivagen Pharmaceuticals Inc
      Usage: Atenolol is indicated for treating hypertension to lower blood pressure, thereby reducing cardiovascular events such as strokes and heart attacks. It is also used for long-term management of angina pectoris and in hemodynamically stable patients to reduce mortality following an acute myocardial infarction.
    • atorvastatin calcium

      (ATORVASTATIN CALCIUM)
      NorthStar RxLLC
      Usage: Atorvastatin calcium tablets are indicated to reduce the risk of cardiovascular events in adults with multiple risk factors or established coronary heart disease, and to lower LDL cholesterol in patients with various forms of hyperlipidemia, including primary hyperlipidemia and familial hypercholesterolemia, in adults and children 10 years and older.
    • atorvastatin calcium

      (ATORVASTATIN CALCIUM)
      Camber Pharmaceuticals, Inc.
      Usage: Atorvastatin calcium tablets are indicated for reducing cardiovascular risks in adults and managing cholesterol levels, including primary hyperlipidemia, heterozygous and homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and hypertriglyceridemia, as well as in patients with diabetes and multiple coronary heart disease risk factors.
    • atorvastatin calcium

      (Atorvastatin Calcium)
      Lupin Pharmaceuticals Inc
      Usage: Atorvastatin calcium is indicated for reducing the risk of myocardial infarction, stroke, and related procedures in adults with risk factors for coronary heart disease, and for lowering LDL cholesterol in patients with hyperlipidemia, familial hypercholesterolemia, and other lipid disorders as an adjunct to diet.
    • atorvastatin calcium

      (Atorvastatin Calcium)
      Teva Pharmaceuticals USA, Inc.
      Usage: Atorvastatin calcium is indicated to reduce the risk of heart-related events in adults with risk factors for coronary heart disease and to lower LDL cholesterol levels in adults and pediatric patients with various forms of hyperlipidemia, including familial hypercholesterolemia and dysbetalipoproteinemia.
    • atorvastatin calcium

      (atorvastatin calcium, film coated)
      Rising Pharma Holdings, Inc.
      Usage: Atorvastatin calcium is indicated to reduce the risk of heart-related issues in adults with multiple risk factors for coronary heart disease and those with type 2 diabetes. It also lowers LDL cholesterol in patients with primary hyperlipidemia, familial hypercholesterolemia, and other lipid disorders.
    • brilinta

      (Ticagrelor)
      AstraZeneca Pharmaceuticals LP
      Usage: BRILINTA is indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It also reduces the risk of first myocardial infarction or stroke in high-risk coronary artery disease patients and ischemic stroke/TIA patients.
    • clopidogrel

      (Clopidogrel)
      NorthStar RxLLC
      Usage: Clopidogrel is indicated for reducing myocardial infarction and stroke rates in patients with acute coronary syndrome (ACS), including unstable angina and ST-elevation myocardial infarction (STEMI). It is also used in patients with recent MI, recent stroke, or established peripheral arterial disease. It should be administered with aspirin.
    • enoxaparin sodium

      (Enoxaparin Sodium)
      Fresenius Kabi USA, LLC
      Usage: Enoxaparin sodium injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction. Additionally, it aids in treating acute ST-segment elevation myocardial infarction.